Supplemental Figure 3: Protection of Cl-2TG mice against DSS-colitis is not strain dependent.
Cl-2TG mice backcrossed (more than 10 generations) to the C57BL/6 strain were used. To induce colitis, mice were provided with DSS (3% w/v) in the drinking water for 7 days. (A). Weight loss during the course of DSS administration; (B). Disease activity index; C (i-ii). Colon length (cm) in control and DSS-treated mice; and C (iii). Colon weight/cm ratio; (D). Cumulative injury scores from the colons of DSS-treated mice; (E). Representative H&E staining of colonic tissues from control and DSS-treated mice. Values are presented as mean} sem. **p<0.01, ***p<0.001. Scale bars=500 or 50 μm.
Supplemental Figure 4:
Details of the histopathological analysis from WT and Cl-2TG mice subjected to DSS-dependent chronic colitis. Values are presented as mean} sem (N#12). *p<0.05, ***p<0.001 versus DSS-treated WT mice.
Supplemental Figure 5:
Representative tables depicting the downregulation of genes associated with epithelial integrity and survival, and upregulation of genes associated with mucosal inflammation. The DSS-treated WT-mice were compared with the control WTmice that received regular drinking water and DSS-treated Cl-2TG mice were compared with DSS-treated WT-mice. (A). Genes associated with proliferation/survival and epithelial integrity; and (B). Genes associated with mucosal inflammation. Fold change in expression and associated P-value is provided.
Supplemental Figure 6: FACS analysis data demonstrating the % enrichment of F480+-cells is presented to demonstrate purity of the macrophages used in our in-vitro activation analysis.
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